Skip to content

Obsidio is now a part of Boston Scientific. Learn More

Technology
Applications
About Us
Press
Publications

Contact

Press

Treatment of Ruptured and Nonruptured Aneurysms Using a Semisolid Iodinated Embolic Agent

April 6, 2022

View Full Story

Technology
Applications
About Us
Press
Publications

© Copyright 2022 Obsidio Privacy Policy Web Design by Beam & Hinge

Twitter
Linked-in

Obsidio's portfolio of products is under development and does not have marketing clearance or approval in any market at this time. For investigational use only. Not available for sale.